Pharmacists in Albuquerque, New Mexico
1083 Pharmacists found in Albuquerque
Dr. Jeffrey Coleman Larsen, PHARMD
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1131 University Blvd Ne, Suite G, Albuquerque, NM 87102
505-272-2341
Dr. Jeffrey Jay Fisher, PHARM.D.
Pharmacist - Pharmacotherapy
1501 San Pedro Dr Se, Albuquerque, NM 87108
505-265-1711
Jenifer Weese, PHARM D
Pharmacist
4700 Cutler Ave Ne, Albuquerque, NM 87110
505-346-1661 505-346-0703
Mrs. Jenna Domzalski De Rios, PHARMD
Pharmacist
2105 Central Ave Nw, Albuquerque, NM 87104
505-242-2713
Mrs. Jennie Elizabeth Tonihka, RPH
Pharmacist
200 Rio Bravo S.e., Albuquerque, NM 87105
505-873-6446 505-873-6407
Jennifer Yoong, JENNIFER YOONG
Pharmacist
6250 Paseo Del Norte Ne, Albuquerque, NM 87113
505-217-2392
Dr. Jennifer Chiawei Abernathy, PHARM.D.
Pharmacist
8011 Harper Dr Ne, Albuquerque, NM 87111
505-858-3134
Jennifer F Prentiss, RPH
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
New Mexico Poison Center Msc09 5080, 1 University Of New Mexico, Albuquerque, NM 87131
505-272-4261
Jennifer L. Haddock, PHARMD.
Pharmacist
2550 Coors Blvd Nw, Albuquerque, NM 87120
505-352-1880 505-352-5727
Dr. Jennifer Arlene Smith, PHARMD., RPH
Pharmacist
5850 Eubank Blvd Ne, Albuquerque, NM 87111
505-217-2819
Ms. Jennifer Scott Griego, PHARM.D.
Pharmacist
1501 San Pedro Dr Se, (119), Albuquerque, NM 87108
505-265-1711 505-265-2789
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.